摘要
This report describes data from two randomized, double-blind clinical trials that investigated COVID-19 rebound following treatment with or without nirmatrelvir/ritonavir.
詳細內容
This report describes data from two randomized, double-blind clinical trials that investigated COVID-19 rebound following treatment with or without nirmatrelvir/ritonavir.
關鍵發現
(需要透過 WebFetch 補充或人工審核來提取關鍵發現)
萃取時間: 2026-02-05T15:10:21Z 資料來源: CDC MMWR